OH HB39 | 2007-2008 | 127th General Assembly
Status
Summary
To amend section 3715.99 and to enact sections 3715.88, 3715.89, and 3715.90 of the Revised Code to require manufacturers and labelers of dangerous drugs to disclose to the Director of Health the value, nature, and purpose of certain gifts, fees, payments, subsidies, and other economic benefits they provide in connection with pharmaceutical detailing, marketing, or promotion.
Title
Drug manufacturers-disclose marketing incentives
Sponsors
| Rep Joyce Beatty | Rep Fred Strahorn | Rep Dan Stewart | Rep Michael Skindell |
| Rep Matt Lundy | Rep Joseph Koziura | Rep Robert F. Hagan | Rep Mike Foley |
| Rep Jennifer Brady | Rep Linda S. Bolon | Rep Peter S. Ujvagi |
History
| Date | Chamber | Action |
|---|---|---|
| 2007-02-20 | To Health | |
| 2007-02-20 | Introduced to House |
Ohio State Sources
| Type | Source |
|---|---|
| Summary | http://www.legislature.state.oh.us/bills.cfm?ID=127_HB_39 |
